Skip to main content

Yoelsis Garcia Mayea

Yoelsis García Mayea, Ph.D., is graduated in Biology by the University of Havana (Cuba) in 2010. He afterwards worked 2 years as a researcher in the area of bee genetics at the Institute of Beekeeping Research in Havana, where he collaborated closely with the Center of Molecular Immunology and the Center for Fisheries Research in Havana, publishing his first article related to the potential use of bee products against atherosclerosis. In 2015 Yoelsis was awarded a predoctoral fellowship from the Vall d'Hebron Hospital Research Institute (VHIR) (Barcelona), where he carried out the necessary research to successfully defend his PhD Thesis in Genetics (University of Barcelona) in 2020. During his predoctoral period he published 10 scientific articles in medium-high impact indexed biomedical journals and has participated in 4 national/international competitive projects. His research has been mainly focused on biomedical oncology research, more specifically on the study of cellular and molecular mechanisms responsible for the acquisition of resistance to chemotherapeutic treatments. As a postdoctoral researcher Yoelsis has continued his research career at the Vall d'Hebron Research Institute, and more recently he has been awarded with a "Margarita Salas" grant from the University of Barcelona, which will allow him to spend 2 years as a postdoctoral researcher at VHIR and at the Autonomous University of Barcelona. He currently has a total of 18 published scientific articles, collaborates as a reviewer in several journals (Autophagy, Cancers, Journal of Translational Medicine, Molecules, Medicina-Lithuania, Frontiers in Bioscience-Landmark, Translational Cancer Research), has directed 2 master's theses, and is co-director of a PhD Thesis. PREVIOUS EXPERIENCE IN LABORATORY WORK: Handling of experimental animals (mice). Molecular biology and molecular genetics: Western Blot; ELISA; qRT-PCR; Cloning; siRNA transfections/shRNA infections. Cell culture: Isolation and characterization of Cancer Stem Cells and establishment of primary cell cultures. Flow cytometry: cell cycle analysis; surface and intracellular markers. Confocal microscopy: analysis of intracellular markers and image processing. Electron microscopy: sample preparation, manipulation, and image acquisition. Biostatistical analysis. Design and writing of research projects.

Institutions of which they are part

Postdoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Vall Hebron Institut de Recerca

Yoelsis Garcia Mayea

Institutions of which they are part

Postdoctoral researcher
Head and Neck Cancer: Biomedical Research Cancer Stem cells
Vall Hebron Institut de Recerca

Yoelsis García Mayea, Ph.D., is graduated in Biology by the University of Havana (Cuba) in 2010. He afterwards worked 2 years as a researcher in the area of bee genetics at the Institute of Beekeeping Research in Havana, where he collaborated closely with the Center of Molecular Immunology and the Center for Fisheries Research in Havana, publishing his first article related to the potential use of bee products against atherosclerosis. In 2015 Yoelsis was awarded a predoctoral fellowship from the Vall d'Hebron Hospital Research Institute (VHIR) (Barcelona), where he carried out the necessary research to successfully defend his PhD Thesis in Genetics (University of Barcelona) in 2020. During his predoctoral period he published 10 scientific articles in medium-high impact indexed biomedical journals and has participated in 4 national/international competitive projects. His research has been mainly focused on biomedical oncology research, more specifically on the study of cellular and molecular mechanisms responsible for the acquisition of resistance to chemotherapeutic treatments. As a postdoctoral researcher Yoelsis has continued his research career at the Vall d'Hebron Research Institute, and more recently he has been awarded with a "Margarita Salas" grant from the University of Barcelona, which will allow him to spend 2 years as a postdoctoral researcher at VHIR and at the Autonomous University of Barcelona. He currently has a total of 18 published scientific articles, collaborates as a reviewer in several journals (Autophagy, Cancers, Journal of Translational Medicine, Molecules, Medicina-Lithuania, Frontiers in Bioscience-Landmark, Translational Cancer Research), has directed 2 master's theses, and is co-director of a PhD Thesis. PREVIOUS EXPERIENCE IN LABORATORY WORK: Handling of experimental animals (mice). Molecular biology and molecular genetics: Western Blot; ELISA; qRT-PCR; Cloning; siRNA transfections/shRNA infections. Cell culture: Isolation and characterization of Cancer Stem Cells and establishment of primary cell cultures. Flow cytometry: cell cycle analysis; surface and intracellular markers. Confocal microscopy: analysis of intracellular markers and image processing. Electron microscopy: sample preparation, manipulation, and image acquisition. Biostatistical analysis. Design and writing of research projects.

ORCID: 0000-0002-9395-7471

Projects

Overcomming chemoresistance in HNSCC

IP: Matilde Lleonart Pajarin
Collaborators: Katerin Ingrid Rojas Laimito, Yoelsis Garcia Mayea, David Virós Porcuna, Josep Castellví Vives, María Garrido Martínez, Pablo Verges Fort, Marina Bataller Fernández
Funding agency: Fundación hna
Funding: 50000
Reference: FUND.HNA/PREMI/LLEONART/2025
Duration: 01/10/2025 - 30/09/2027

Degradadores moleculares de SFN para sensibilizar células tumorales de cabeza y cuello (HNSCC) resistentes a terapias convencionales (ANTCANRES)

IP: Matilde Lleonart Pajarin
Collaborators: Yoelsis Garcia Mayea
Funding agency: Fundació Institut Bioenginyeria de Catalunya
Funding: 0.01
Reference: K9086
Duration: 24/07/2023 - 24/07/2024

Establecimiento de una estrategia combinada en carcinoma escamoso de cabeza y cuello (HNSCC): una herramienta eficaz para superar los tumores quimiorresistentes.

IP: Matilde Lleonart Pajarin
Collaborators: Katerin Ingrid Rojas Laimito, Yoelsis Garcia Mayea, Juan Lorente Guerrero, Juan Fernando Fuentes Cabrera, Sergio Benavente Norza, Josep Castellví Vives, Marina Bataller Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 240000
Reference: PI24/00630
Duration: 01/01/2025 - 31/12/2027

Nanocápsulas que combinan nuevos fármacos con quimioterapia convencional para curar cánceres resistentes

IP: Matilde Lleonart Pajarin
Collaborators: Katerin Ingrid Rojas Laimito, Irene Braña Garcia, Yoelsis Garcia Mayea, David Virós Porcuna, Juan Fernando Fuentes Cabrera, Josep Castellví Vives, Marina Bataller Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 318750
Reference: AC24/00057
Duration: 01/01/2025 - 31/12/2027

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

Researchers from the Vall d’Hebron Research Institute (VHIR) have participated in a study showing that, after just a few seconds of illumination, the activated molecule prevents the formation of tumor spheres.

Experts addressed the main current and future challenges to improve therapeutic options for patients with this type of tumor.

Related professionals

Nerea Fernández Ortega

Nerea Fernández Ortega

Gestió i Administració
Commercial and Academic Clinical Research
Read more
Celia Sánchez Campaña

Celia Sánchez Campaña

Predoctoral researcher
Infectious Diseases
Read more
Estefa Choque Apaico

Estefa Choque Apaico

Maintenance staff and general services
Infectious Diseases
Read more
Claudia Meza Burgos

Claudia Meza Burgos

Research technician
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.